Fibroblast Growth Factor-21 as a Therapeutic Agent for Metabolic Diseases
- 1 January 2008
- journal article
- review article
- Published by Springer Nature in BioDrugs
- Vol. 22 (1) , 37-44
- https://doi.org/10.2165/00063030-200822010-00004
Abstract
Fibroblast growth factor (FGF)-21 is a unique member of the FGF family, with several molecular characteristics that differ from classical FGFs and exhibiting a pharmacologic profile that includes a...Keywords
This publication has 1 reference indexed in Scilit:
- Phenotypical Enrichment Strategies for Microarray Data Analysis Applied in a Type II Diabetes StudyOMICS: A Journal of Integrative Biology, 2005